OR WAIT null SECS
November 03, 2021
Janssen Sciences Ireland was honored for its project execution of a large-scale expansion of biologics drug substance fed-batch capacity.
November 02, 2021
An annual survey on inspections and audits has revealed opportunities to use more flexible approaches to optimize processes.
Takeda’s acquisition of GammaDelta Therapeutics expands their immuno-oncology and innate immune cell therapy portfolio.
Aceragen’s acquisition of Arrevus adds key treatment candidates to its rare disease pipeline.
Novartis’ scemblix (asciminib) is designed to provide a single treatment option to patients struggling with chronic myeloid leukemia.
Following the acquisition, Avantor will have access to Masterflex’s various bioproduction operations.
Manufacturing capacity expansion is high on the agenda for many bio/pharma companies and service providers in Europe.
November 01, 2021
Abbvie’s Vuity (pilocarpine HCI ophthalmic solution) is the first and only eye drop to receive FDA approval for the treatment of presbyopia.
